Get the Stockscreener App
30.88
3.08%
-0.98
Veracyte Inc stock is traded at $30.88, with a volume of 612.86K.
It is down -3.08% in the last 24 hours and up +7.33% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$31.86
Open:
$31.59
24h Volume:
612.86K
Relative Volume:
0.43
Market Cap:
$2.43B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-41.17
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
-4.78%
1M Performance:
+7.33%
6M Performance:
-0.26%
1Y Performance:
+1.51%
1-Day Range:
$30.85
$31.62
1-Week Range:
$30.67
$32.79
52-Week Range:
$22.61
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
30.88 | 2.42B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
479.46 | 179.95B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
190.05 | 137.90B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
641.14 | 51.04B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
123.24 | 35.19B | 6.79B | 1.22B | 1.09B | 4.26 |
|
IQV
Iqvia Holdings Inc
|
187.22 | 31.26B | 15.70B | 1.24B | 2.01B | 6.91 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Veracyte, Inc. $VCYT Stake Trimmed by Great Lakes Advisors LLC - MarketBeat
Veracyte (NASDAQ:VCYT) CEO Sells $233,153.47 in Stock - MarketBeat
Is Veracyte Inc. still worth holding after the dip2025 Geopolitical Influence & Weekly Top Performers Watchlists - Newser
Can trapped investors hope for a rebound in Veracyte Inc.Trade Entry Summary & Low Risk Entry Point Tips - Newser
Will Veracyte Inc. stock go up soonQuarterly Trade Summary & High Yield Stock Recommendations - Newser
Real time scanner hits for Veracyte Inc. explainedEntry Point & Low Risk Entry Point Tips - Newser
Tools to monitor Veracyte Inc. recovery probabilityJuly 2025 Trends & Risk Managed Investment Signals - Newser
Price momentum metrics for Veracyte Inc. explainedQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
Will earnings trigger a reversal in Veracyte Inc.July 2025 WrapUp & Free Daily Entry Point Trade Alerts - Newser
Bridgeway Capital Management LLC Sells 41,300 Shares of Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Veracyte, Inc. $VCYT Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation By Investing.com - Investing.com South Africa
Transcript : Veracyte, Inc. Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 04 - MarketScreener
Veracyte at Morgan Stanley Conference: Strategic Growth and Innovation - Investing.com
Veracyte Announces That More Than 10 Afirma-Focused Studies Will Be Presented at the 2025 American Thyroid Association Annual Meeting - Business Wire
Raymond James Financial Inc. Raises Stake in Veracyte, Inc. $VCYT - MarketBeat
Veracyte CEO Stapley sells $233k in shares By Investing.com - Investing.com South Africa
Veracyte CEO Stapley sells $233k in shares - Investing.com India
Can Veracyte Inc. expand into new marketsWeekly Stock Report & Low Drawdown Momentum Trade Ideas - beatles.ru
Is Veracyte Inc. stock forming a triangle patternPortfolio Value Summary & Fast Gain Stock Trading Tips - beatles.ru
PDT Partners LLC Trims Stock Position in Veracyte, Inc. $VCYT - MarketBeat
What are the future prospects of Veracyte Inc.July 2025 Retail & Weekly Top Gainers Alerts - 뉴스영
Trexquant Investment LP Has $5.59 Million Stake in Veracyte, Inc. $VCYT - MarketBeat
Is Veracyte Inc. stock ready for a breakout2025 Performance Recap & AI Driven Stock Reports - Newser
Can Veracyte Inc. continue delivering strong returnsWeekly Stock Summary & Free Growth Oriented Trading Recommendations - خودرو بانک
Magnetar Financial LLC Makes New Investment in Veracyte, Inc. $VCYT - MarketBeat
Veracyte, Inc. (NASDAQ:VCYT) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Volatility clustering patterns for Veracyte Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
Can Veracyte Inc. hit a new high this monthQuarterly Trade Report & Daily Market Momentum Tracking - Newser
Using Ichimoku Cloud for Veracyte Inc. technicalsCPI Data & Proven Capital Preservation Methods - Newser
Can Veracyte Inc. rally from current levelsPortfolio Value Report & Long-Term Investment Growth Plans - Newser
Does Veracyte Inc. have strong fundamentalsMarket Risk Report & Community Verified Trade Alerts - خودرو بانک
How to use Fibonacci retracement on Veracyte Inc.Weekly Trade Report & Low Risk Investment Opportunities - Newser
Will Veracyte Inc. price bounce be sustainableWeekly Loss Report & Free Long-Term Investment Growth Plans - Newser
Hsbc Holdings PLC Boosts Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
Full technical analysis of Veracyte Inc. stockBreakout Watch & Real-Time Buy Signal Alerts - Newser
Is Veracyte Inc. forming a double bottomJuly 2025 Weekly Recap & Daily Entry Point Trade Alerts - خودرو بانک
How to recover losses in Veracyte Inc. stockRecession Risk & Long-Term Safe Investment Plans - Newser
What is the long term forecast for Veracyte Inc. stockPortfolio Gains Report & Fast Momentum Entry Tips - خودرو بانک
Can Veracyte Inc. recover in the next quarter2025 Support & Resistance & Risk Controlled Swing Alerts - Newser
Using data filters to optimize entry into Veracyte Inc.July 2025 PreEarnings & Risk Controlled Daily Plans - Newser
Veracyte, Inc. $VCYT Shares Bought by Rafferty Asset Management LLC - MarketBeat
Driehaus Capital Management LLC Grows Stock Holdings in Veracyte, Inc. $VCYT - MarketBeat
What hedge funds are buying Veracyte Inc.Market Risk Summary & Real-Time Volume Surge Alerts - خودرو بانک
Russell Investments Group Ltd. Lowers Holdings in Veracyte, Inc. $VCYT - MarketBeat
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.33%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):